Elaine O'Hara
Corporate Officer/Principal chez NOVAVAX, INC.
Fortune : 67 996 $ au 31/03/2024
Profil
Elaine O'Hara has held positions as President & Director at Sanofi Pasteur VaxDesign Corp.
and currently holds the position of Chief Strategy Officer at Novavax, Inc.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
NOVAVAX, INC.
0,01% | 01/03/2024 | 14 225 ( 0,01% ) | 67 996 $ | 31/03/2024 |
Postes actifs de Elaine O'Hara
Sociétés | Poste | Début |
---|---|---|
NOVAVAX, INC. | Corporate Officer/Principal | 01/03/2023 |
Sanofi Pasteur VaxDesign Corp.
Sanofi Pasteur VaxDesign Corp. Miscellaneous Commercial ServicesCommercial Services Sanofi Pasteur VaxDesign Corp. designs, develops, and manufactures in vitro models of the human immune system. The firm engages in preventing infectious disease by forecasting vaccine responses before clinical trials by providing predictive in vitro immunological models and assays. The company was founded by William Warren in 2004 and is headquartered in Orlando, FL. | President | - |
Formation de Elaine O'Hara
National University of Ireland | Undergraduate Degree |
Saint Joseph's University Haub School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
NOVAVAX, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Sanofi Pasteur VaxDesign Corp.
Sanofi Pasteur VaxDesign Corp. Miscellaneous Commercial ServicesCommercial Services Sanofi Pasteur VaxDesign Corp. designs, develops, and manufactures in vitro models of the human immune system. The firm engages in preventing infectious disease by forecasting vaccine responses before clinical trials by providing predictive in vitro immunological models and assays. The company was founded by William Warren in 2004 and is headquartered in Orlando, FL. | Commercial Services |